Alana Pimentel Moura Selected Research

HHH syndrome

8/2013	Disturbance of redox homeostasis by ornithine and homocitrulline in rat cerebellum: a possible mechanism of cerebellar dysfunction in HHH syndrome.
12/2012	Chronic postnatal ornithine administration to rats provokes learning deficit in the open field task.
12/2012	Impairment of brain redox homeostasis caused by the major metabolites accumulating in hyperornithinemia-hyperammonemia-homocitrullinuria syndrome in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alana Pimentel Moura Research Topics

Disease

3	Nonketotic Hyperglycinemia 01/2018 - 11/2013
3	Metabolic Diseases (Metabolic Disease) 11/2013 - 03/2012
3	Peroxisomal Disorders (Peroxisomal Disorder) 03/2012 - 09/2010
2	Sulfite oxidase deficiency 01/2017 - 12/2013
2	Seizures (Absence Seizure) 01/2017 - 11/2016
2	Refsum Disease (Refsum's Disease) 07/2012 - 09/2010
1	Necrosis 01/2021
1	Glutaric Acidemia I 01/2021
1	Neuroinflammatory Diseases 01/2021
1	Neoplasms (Cancer) 01/2021
1	Proteinuria 03/2018
1	Albuminuria 03/2018
1	Fabry Disease (Fabry's Disease) 03/2018
1	Brain Diseases (Brain Disorder) 01/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2017
1	Cerebellar Diseases (Cerebellar Syndrome) 08/2013
1	Ataxia (Dyssynergia) 08/2013
1	Cerebellar Ataxia (Dysmetria) 08/2013
1	Hyperammonemia 12/2012
1	Inborn Genetic Diseases (Disease, Hereditary) 12/2012
1	Body Weight (Weight, Body) 12/2012
1	Intellectual Disability (Idiocy) 12/2012
1	Cardiomyopathies (Cardiomyopathy) 07/2012
1	Neurologic Manifestations (Neurological Manifestations) 06/2011
1	Propionic Acidemia 07/2010
1	Ethylmalonic encephalopathy 02/2010
1	Medium chain acyl CoA dehydrogenase deficiency 11/2009

Drug/Important Bio-Agent (IBA)

5	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2018 - 11/2009
3	SulfitesIBA 01/2017 - 12/2013
3	HHH syndromeIBA 08/2013 - 12/2012
2	Carnitine (L-Carnitine)FDA LinkGeneric 01/2021 - 11/2009
2	AcidsIBA 01/2021 - 11/2009
2	Sulfite OxidaseIBA 01/2017 - 11/2016
2	ThiosulfatesIBA 11/2016 - 12/2013
2	AmmoniaIBA 08/2013 - 12/2012
2	homocitrullineIBA 08/2013 - 12/2012
2	OrnithineIBA 08/2013 - 12/2012
2	Biological ProductsIBA 07/2012 - 02/2010
2	Phytanic AcidIBA 07/2012 - 09/2010
1	glutaric acidIBA 01/2021
1	glutarylcarnitineIBA 01/2021
1	Amino Acids FDA Link 01/2021
1	Cathepsin DIBA 01/2021
1	InterleukinsIBA 01/2021
1	Lysine (L-Lysine)FDA Link 01/2021
1	Tryptophan (L-Tryptophan)FDA Link 01/2021
1	Glutaryl-CoA DehydrogenaseIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 03/2018
1	Urea (Carbamide)FDA LinkGeneric 03/2018
1	globotriaosylceramide (globotriosylceramide)IBA 03/2018
1	GalactosidasesIBA 03/2018
1	CreatinineIBA 03/2018
1	HydrolasesIBA 03/2018
1	BezafibrateIBA 01/2017
1	AntioxidantsIBA 01/2017
1	S-sulphocysteineIBA 11/2016
1	UreaseIBA 12/2012
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2012
1	CatalaseIBA 12/2012
1	Glutathione (Reduced Glutathione)IBA 12/2012
1	Glutathione PeroxidaseIBA 12/2012
1	Glutamic Acid (Glutamate)FDA Link 03/2012
1	beta-methylcrotonylglycineIBA 03/2012
1	NAD (NADH)IBA 03/2012
1	malic acid (malate)IBA 03/2012
1	Succinic Acid (Succinate)IBA 03/2012
1	pristanic acidIBA 06/2011
1	ethylmalonic acid (ethylmalonate)IBA 02/2010
1	Butyryl-CoA Dehydrogenase (Short-Chain Acyl-CoA Dehydrogenase)IBA 02/2010
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2009

Therapy/Procedure

1	Enzyme Replacement Therapy 03/2018
1	Subcutaneous Injections 12/2012